- Conditions
- Congenital Pseudarthrosis of Tibia
- Interventions
- NVD003, Iliac Crest Bone Graft
- Biological · Procedure
- Lead sponsor
- Novadip Biosciences
- Industry
- Eligibility
- Up to 17 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 4
- States / cities
- Phoenix, Arizona • Loma Linda, California • Baltimore, Maryland + 1 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–3
of 3
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Congenital Pseudarthrosis of Tibia
- Interventions
- NVD-003, an autologous 3D scaffold free osteogenic graft
- Biological
- Lead sponsor
- Novadip Biosciences
- Industry
- Eligibility
- 2 Years to 8 Years
- Enrollment
- 4 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2026
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- NF1, Congenital Pseudarthrosis of Tibia
- Interventions
- INFUSE Bone Graft (BMP-2), Control Group
- Device · Procedure
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 2 Years to 18 Years
- Enrollment
- 5 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2020
- U.S. locations
- 15
- States / cities
- Birmingham, Alabama • Los Angeles, California • Washington D.C., District of Columbia + 10 more